L
Lisa M. Noguchi
Researcher at Johns Hopkins University
Publications - 28
Citations - 1282
Lisa M. Noguchi is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 7, co-authored 23 publications receiving 1091 citations. Previous affiliations of Lisa M. Noguchi include University of Pittsburgh & Jhpiego.
Papers
More filters
Journal ArticleDOI
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
Jeanne M. Marrazzo,Gita Ramjee,Barbra A. Richardson,Kailazarid Gomez,Nyaradzo Mgodi,Gonasagrie Nair,Thesla Palanee,Clemensia Nakabiito,Ariane van der Straten,Lisa M. Noguchi,Craig W. Hendrix,James Y. Dai,S. Ganesh,Baningi Mkhize,Marthinette Taljaard,Urvi M. Parikh,Jeanna M. Piper,Benoît Mâsse,Benoît Mâsse,Cynthia I. Grossman,James F. Rooney,Jill L. Schwartz,Heather Watts,Mark A. Marzinke,Sharon L. Hillier,Ian McGowan,Z. Mike Chirenje +26 more
TL;DR: None of the drug regimens evaluated reduced the rates of HIV-1 acquisition in an intention-to-treat analysis, and adherence to study drugs was low.
Journal ArticleDOI
Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study
Lisa M. Noguchi,Barbra A. Richardson,Jared M. Baeten,Sharon L. Hillier,Jennifer E. Balkus,Z. Mike Chirenje,Katherine E. Bunge,Gita Ramjee,Gonasagrie Nair,Thesla Palanee-Phillips,Pearl Selepe,Ariane van der Straten,Urvi M. Parikh,Kailazarid Gomez,Jeanna M. Piper,D. Heather Watts,Jeanne M. Marrazzo +16 more
TL;DR: NET-EN might be an alternative injectable drug with a lower HIV risk than DMPA in high HIV-1 incidence settings where NET-EN is available, and moderate associations in observational analyses should be interpreted with caution.
Journal ArticleDOI
Pharmacokinetics and Placental Transfer of Single-Dose Tenofovir 1% Vaginal Gel in Term Pregnancy
Richard H. Beigi,Lisa M. Noguchi,Teresa L. Parsons,Ingrid Macio,Ratiya Pamela Kunjara Na Ayudhya,Jianmeng Chen,Craig W. Hendrix,Benoît Mâsse,Benoît Mâsse,Megan Valentine,Jeanna M. Piper,D. Heather Watts +11 more
TL;DR: Findings support ongoing and future investigations of TFV gel in pregnancy and support the found to decrease sexual transmission of human immunodeficiency virus.
Journal ArticleDOI
Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy
Bonus Makanani,Jennifer E. Balkus,Yuqing Jiao,Lisa M. Noguchi,Thesla Palanee-Phillips,Yamikani Mbilizi,Jothi Moodley,Kenneth Kintu,Krishnaveni Reddy,Samuel Kabwigu,Nitesha Jeenariain,Ishana Harkoo,Nyaradzo Mgodi,Jeanna M. Piper,Helen Rees,Rachel Scheckter,Richard H. Beigi,Jared M. Baeten +17 more
TL;DR: Dapivirine use in the periconception period does not seem to be associated with adverse effects on pregnancy or infant outcomes, and these findings provide support for additional safety studies of the dapvirine ring throughout pregnancy.
Journal ArticleDOI
Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring
Lisa M. Noguchi,Craig J. Hoesley,Cliff Kelly,Rachel Scheckter,Katherine E. Bunge,Annalene Nel,Mark A. Marzinke,Craig W. Hendrix,Charlene S. Dezzutti,Sharon L. Hillier,Debra L. Bogen,Jeanna M. Piper,Richard H. Beigi +12 more
TL;DR: In this first study of dapvirine exposure during lactation, dapivirine VR use was associated with lower concentrations of detectable dapavirine in milk and plasma than in CVF samples and a favorable safety profile.